Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R CONNELL

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Journal of Crohn'S & Colitis|January 5, 2025
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn's perianal fistulasMichael De Gregorio, Leon S Winata, Imogen Hartley, et al.
Journal of Gastroenterology and Hepatology|December 16, 2016
Serologic antibodies in relation to outcome in postoperative Crohn's diseaseAmy L Hamilton, Michael A Kamm, Peter De Cruz, et al.
Journal of Crohn'S & Colitis|February 1, 2018
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's DiseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Microbiology Resource Announcements|August 20, 2024
Genome sequence of Xenia2 a DV cluster phage that infects <i>Gordonia rubripertincta</i>Carol Agaiby, Maha Ahmed, Aidan Argueta, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.
Lancet (London, England)|December 28, 2014
Crohn's disease management after intestinal resection: a randomised trialPeter De Cruz, Michael A Kamm, Amy L Hamilton, et al.
Journal of Crohn'S & Colitis|April 10, 2015
Effect of intestinal resection on quality of life in Crohn's diseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Journal of Crohn'S & Colitis|January 5, 2025
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn's perianal fistulasMichael De Gregorio, Leon S Winata, Imogen Hartley, et al.
Journal of Gastroenterology and Hepatology|December 16, 2016
Serologic antibodies in relation to outcome in postoperative Crohn's diseaseAmy L Hamilton, Michael A Kamm, Peter De Cruz, et al.
Journal of Crohn'S & Colitis|February 1, 2018
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's DiseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Microbiology Resource Announcements|August 20, 2024
Genome sequence of Xenia2 a DV cluster phage that infects <i>Gordonia rubripertincta</i>Carol Agaiby, Maha Ahmed, Aidan Argueta, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.
Lancet (London, England)|December 28, 2014
Crohn's disease management after intestinal resection: a randomised trialPeter De Cruz, Michael A Kamm, Amy L Hamilton, et al.
Journal of Crohn'S & Colitis|April 10, 2015
Effect of intestinal resection on quality of life in Crohn's diseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Pageof 14